News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,128 Results
Type
Article (14415)
Company Profile (18)
Press Release (177695)
Section
Business (69121)
Career Advice (1607)
Deals (9588)
Drug Delivery (85)
Drug Development (32661)
Employer Resources (77)
FDA (4970)
Job Trends (4678)
News (114074)
Policy (8316)
Tag
Academia (965)
Alliances (11603)
Alzheimer's disease (476)
Antibody-drug conjugate (ADC) (62)
Approvals (4929)
Artificial intelligence (71)
Bankruptcy (87)
Best Places to Work (3916)
Biosimilars (44)
Breast cancer (67)
Cancer (508)
Cardiovascular disease (54)
Career advice (1302)
CAR-T (57)
Cell therapy (143)
Clinical research (25906)
Collaboration (139)
COVID-19 (1167)
C-suite (93)
Data (432)
Diabetes (54)
Diagnostics (1984)
Drug pricing (59)
Earnings (17989)
Employer resources (75)
Events (20758)
Executive appointments (294)
FDA (5167)
Funding (145)
Gene editing (41)
Gene therapy (106)
GLP-1 (362)
Government (1537)
Healthcare (6295)
Infectious disease (1196)
Inflammatory bowel disease (44)
Interviews (327)
IPO (4258)
Job creations (845)
Job search strategy (1079)
Layoffs (201)
Legal (1311)
Lung cancer (100)
Manufacturing (82)
Medical device (4813)
Medtech (4815)
Mergers & acquisitions (5381)
Metabolic disorders (218)
Neuroscience (622)
NextGen Class of 2024 (2245)
Non-profit (1577)
Northern California (531)
Obesity (138)
Opinion (174)
People (35680)
Phase I (11334)
Phase II (10955)
Phase III (7251)
Pipeline (211)
Podcasts (81)
Policy (51)
Postmarket research (596)
Preclinical (2587)
Radiopharmaceuticals (105)
Rare diseases (107)
Real estate (1446)
Regulatory (5932)
Research institute (847)
Resumes & cover letters (275)
Southern California (418)
Startups (1214)
The Weekly (50)
United States (4321)
Vaccines (290)
Weight loss (142)
Date
Today (55)
Last 7 days (302)
Last 30 days (1324)
Last 365 days (13083)
2024 (11879)
2023 (14647)
2022 (16547)
2021 (18148)
2020 (17272)
2019 (15441)
2018 (11908)
2017 (10792)
2016 (9613)
2015 (10701)
2014 (7662)
2013 (6211)
2012 (6484)
2011 (6760)
2010 (5443)
Location
Africa (350)
Asia (13444)
Australia (2317)
California (1112)
Canada (399)
China (114)
Colorado (61)
Connecticut (59)
Europe (31377)
Florida (138)
Illinois (117)
Indiana (62)
Maryland (161)
Massachusetts (777)
Minnesota (94)
New Jersey (295)
New York (335)
North Carolina (255)
Northern California (531)
Ohio (48)
Pennsylvania (270)
South America (443)
Southern California (418)
Texas (155)
Washington State (114)
192,128 Results for "i mab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
I-Mab to Participate at the Piper Sandler Healthcare Conference
November 21, 2024
·
1 min read
Press Releases
I-Mab Reports Third Quarter 2024 Results
November 15, 2024
·
17 min read
Business
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
I-Mab today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer.
June 6, 2024
·
5 min read
Press Releases
I-Mab to Participate at the Truist Securities BioPharma Symposium
October 28, 2024
·
1 min read
Press Releases
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
November 6, 2024
·
5 min read
BioCapital
I-Mab to Participate at the 2024 Jefferies Global Healthcare Conference
I-Mab, a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.
May 22, 2024
·
1 min read
Press Releases
I-Mab to Release Q3 2024 Financial Results on November 14, 2024
November 1, 2024
·
1 min read
Press Releases
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
October 30, 2024
·
2 min read
BioCapital
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
I-Mab announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.
April 5, 2024
·
1 min read
Business
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
I-Mab enters clinical collaboration with Bristol Myers Squibb to evaluate Claudin 18.2 x 4-1BB bispecific antibody givastomig in combination with nivolumab and chemotherapy for the treatment of gastric and esophageal cancer.
June 5, 2024
·
6 min read
1 of 19,213
Next
